Reaktion #1128066

ord-11c563f93ee24511a3ec278f93942d71

Reaktionsgleichung

CNC(=O)c1cccc(F)c1Nc1nc(Cl)ncc1Cl
2-(2,5-Dichloro-pyrimidin-4-ylamino)-3-fluoro-N-methyl-benzamide
CC1(C)CCC(=O)Nc2ccc(N)cc21
7-Amino-5,5-dimethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one
CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)O)C(=O)C2
DL-10-Camphorsulfonic acid
CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)C(C)(C)CCC(=O)N3)ncc1Cl
2-[5-Chloro-2-(5,5-dimethyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-3-fluoro-N-methyl-benzamide
Ausbeute 26.0%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeMicrowaved
  2. 2
    Sonstigereaction at 120° C. for 70 minutes
  3. 3
    SonstigeEvaporated off solvent
  4. 4
    Sonstigepurified with normal phase chromatography

Vorschrift

Combined 2-(2,5-Dichloro-pyrimidin-4-ylamino)-3-fluoro-N-methyl-benzamide (73 mg, 0.232 mmol), 7-Amino-5,5-dimethyl-1,3,4,5-tetrahydro-benzo[b]azepin-2-one (57 mg, 0.279 mmol), DL-10-Camphorsulfonic acid (67 mg, 0.288 mmol) and isopropanol (4 mL) in a microwave tube. Microwaved reaction at 120° C. for 70 minutes. Evaporated off solvent and purified with normal phase chromatography to yield a yellow solid, 2-[5-Chloro-2-(5,5-dimethyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-7-ylamino)-pyrimidin-4-ylamino]-3-fluoro-N-methyl-benzamide (29 mg, 26%). mp 153° C.; LCMS: m/z=483.37 (M+H+), 1H NMR (400 MHz, CDCl3) δ 8.89 (s, 1H), 8.07 (s, 1H), 7.96 (s, 1H), 7.61 (s, 1H), 7.53 (d, 1H, J=8.6 Hz), 7.27 (m, 3H), 6.70 (m, 2H), 6.40 (m, 1H), 2.92 (d, 3H, J=4.8 Hz), 2.32 (m, 2H), 2.04 (m, 2H), 1.30 (s, 6H).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08552186B2uspto-grants-2013_10